CDKN1B and diabetic kidney disease: Inhibitors of cyclin-dependent kinases (Cdk) such as p27Kip1, a negative cell cycle regulator, are involved in the development of diabetic nephropathy, with associated mesangial hypertrophy and extracellular matrix accumulation [10-13].